14574 Federal Register / Vol. 74, No. 60 / Tuesday, March 31, 2009 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Regulation of Cytokine 

Transcription and Inflammation. 

Date: March 30, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Jay Bruce Sundstrom, PhD, 

Scientific Review Officer, Scientific Review 

Program, DEA/NIAID/NIH/DHHS, Room 

3119, 6700B Rockledge Drvie, MSC–7616, 

Bethesda, MD 20892–7616, 301–496–7042, 

sundstromj@niaid.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; B Cell Epitope Discovery 

and Mechanisms of Antibody Protection. 

Date: April 20–21, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: The Legacy Hotel and Meeting 

Centre, 1775 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Quirijn Vos, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIH/NIAID/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892, 301–451– 

2666, qvos@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Rapid HIV Point-of-Care 

Diagnostic Device for Resource-Limited 

Setting. 

Date: April 20–21, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Doubletree Hotel and Executive 

Meeting Center, 8120 Wisconsin Ave, 

Bethesda, MD 20814. 

Contact Person: Roberta Binder, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIAID/NIH/DHHS, 6700B Rockledge Drive, 

MSC 7616, Room 3130, Bethesda, MD 20892– 

7616, 301–496–7966, rbinder@niaid.nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Ancillary Studies in 

Immunomodulation Clinical Trials. 

Date: April 24, 2009. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: Paul A. Amstad, PhD, 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

NIAID/NIH/DHHS, 6700B Rockledge Drive, 

MSC 7616, Bethesda, MD 20892–7616, 301– 

402–7098, pamstad@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 25, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–7197 Filed 3–30–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

Scientific Management Review Board. 

The NIH Reform Act of 2006 (Pub. L. 

109–482) provides organizational 

authorities to HHS and NIH officials to: 

(1) Establish or abolish national research 

institutes; (2) reorganize the offices 

within the Office of the Director, NIH, 

including adding, removing, or 

transferring the functions of such offices 

or establishing or terminating such 

offices; and (3) reorganize, divisions, 

centers, or other administrative units 

within an NIH national research 

institute or national center including 

adding, removing, or transferring the 

functions of such units, or establishing 

or terminating such units. The purpose 

of the Scientific Management Review 

Board (also referred to as SMRB or 

Board) is to advise appropriate HHS and 

NIH officials on the use of these 

organizational authorities and identify 

the reasons underlying the 

recommendations. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Scientific 

Management Review Board. 

Date: April 27–28, 2009. 

Open: April 27, 2009, 8:30 a.m. to 5:30 

p.m. 

Agenda: Presentation and discussion will 

include an overview of NIH mission, 

structure, budget, perspectives on how 

science has shaped the NIH organization, and 

future directions. There will also be time 

allotted on the agenda for public comment. 

Sign up for public comment will begin at 

approximately 8 a.m. on both April 27 and 

28. In the event that time does not allow for 

all those interested to present oral comments, 

anyone may file written comments using the 

address below. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 6, 

31 Center Drive, Bethesda, MD 20892. 

Open: April 28, 2009, 8:30 a.m. to 3:30 

p.m. 

Agenda: Continuation of April 27th 

meeting. 

Place: National Institutes of Health, 

Building 31, 6th Floor, Conference Room 6, 

31 Center Drive, Bethesda, MD 20892. 

Contact Person: Dr. Lyric Jorgenson, PhD, 

NIH–AAAS Science and Technology Policy 

Fellow, Office of Science Policy, Office of the 

Director, NIH, National Institutes of Health, 

Building 1 Room 218 MSC 0166, 9000 

Rockville Pike, Bethesda, MD 20892. 

smrb@mail.nih.gov. (301) 496–6837. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

The meeting will also be Web cast. The 

draft meeting agenda and other information 

about the SMRB, including information about 

access to the Web cast, will be available at 

http://smrb.od.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Dated: March 25, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–7200 Filed 3–30–09; 8:45 am] 

BILLING CODE 4140–01–P 


tjames on PRODPC61 with NOTICES